GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Whanin Pharm Co Ltd (XKRX:016580) » Definitions » Net Margin %

Whanin Pharm Co (XKRX:016580) Net Margin % : 14.72% (As of Mar. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Whanin Pharm Co Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Whanin Pharm Co's Net Income for the three months ended in Mar. 2024 was ₩9,071 Mil. Whanin Pharm Co's Revenue for the three months ended in Mar. 2024 was ₩61,610 Mil. Therefore, Whanin Pharm Co's net margin for the quarter that ended in Mar. 2024 was 14.72%.

The historical rank and industry rank for Whanin Pharm Co's Net Margin % or its related term are showing as below:

XKRX:016580' s Net Margin % Range Over the Past 10 Years
Min: 11.6   Med: 13.77   Max: 18.37
Current: 13.42


XKRX:016580's Net Margin % is ranked better than
77.75% of 1020 companies
in the Drug Manufacturers industry
Industry Median: 3.225 vs XKRX:016580: 13.42

Whanin Pharm Co Net Margin % Historical Data

The historical data trend for Whanin Pharm Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Whanin Pharm Co Net Margin % Chart

Whanin Pharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.75 13.62 15.00 12.02 12.92

Whanin Pharm Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.82 15.18 10.78 12.96 14.72

Competitive Comparison of Whanin Pharm Co's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Whanin Pharm Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Whanin Pharm Co's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Whanin Pharm Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where Whanin Pharm Co's Net Margin % falls into.



Whanin Pharm Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Whanin Pharm Co's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=29774.322/230393.579
=12.92 %

Whanin Pharm Co's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin=Net Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=9071.223/61610.033
=14.72 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Whanin Pharm Co  (XKRX:016580) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Whanin Pharm Co Net Margin % Related Terms

Thank you for viewing the detailed overview of Whanin Pharm Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Whanin Pharm Co (XKRX:016580) Business Description

Traded in Other Exchanges
N/A
Address
84-1 Munjeong-dong, Songpa-gu, Seoul, KOR, 138-200
Whanin Pharm Co Ltd is a pharmaceutical company. The company develops, manufactures, markets, and sells the therapeutic products. It offers antibiotics, cardiovascular drugs, CNS stimulants, gastrointestinal drugs, multivitamins and other products. The company's products include Antiasthmatics; Antidepressants; Antipsychotics; Anxiolytics and hypnotics; and Antiepileptics.

Whanin Pharm Co (XKRX:016580) Headlines

No Headlines